Quantification of fibrin degradation products in glioma and meningioma patients


CAN Ö. , Erdemgil Y., Yildirim Z. Z. , ÖZDUMAN K. , Pamir M. N. , Sav A., et al.

CANCER BIOMARKERS, cilt.14, ss.253-258, 2014 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 14 Konu: 4
  • Basım Tarihi: 2014
  • Doi Numarası: 10.3233/cbm-140400
  • Dergi Adı: CANCER BIOMARKERS
  • Sayfa Sayısı: ss.253-258

Özet

BACKGROUND: DR-70 is an immunoassay for fibrin and FDP in plasma and it has been shown useful in detection of over 14 different cancers. This study investigated the validity of the DR-70 test in gliomas as well as meningiomas.